SAR 23.44
(-0.51%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 153.36 Million | 114.14 Million | 181.59 Million | 99.12 Million | 114.46 Million | 100.68 Million |
Net Income | 36.41 Million | 94.46 Million | 98.81 Million | 23.1 Million | 87.98 Million | 47.97 Million |
Depreciation & Amortization | 34.17 Million | 33.08 Million | 34.01 Million | 32.87 Million | 28.82 Million | 18.33 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 10.06 Million | -46.09 Million | 17.25 Million | 4.25 Million | -14.85 Million | -21.45 Million |
Other non-cash items | 72.7 Million | 32.69 Million | 31.5 Million | 38.88 Million | 12.5 Million | 52.71 Million |
Investing Cash Flow | -203.1 Million | -86.71 Million | -89.93 Million | -223.42 Million | -261.65 Million | -80.41 Million |
Investments in PPE | -2.26 Million | -487.34 Thousand | -293.13 Thousand | -743.63 Thousand | -624.1 Thousand | -689.85 Thousand |
Acquisitions | -13 Million | -30.1 Million | -43.52 Million | -6.25 Million | -11.12 Million | -1.81 Million |
Investment purchases | -285.69 Million | -80 Million | -89.63 Million | -264.94 Million | -277.51 Million | -79.72 Million |
Sales/Maturities of investments | 84.85 Million | 40.05 Million | 89.63 Million | 42.26 Million | 15.84 Million | - |
Other Investing Activities | 13 Million | -16.18 Million | -46.11 Million | 6.25 Million | 11.76 Million | -80.41 Million |
Financing Cash Flow | 87.53 Million | -89.05 Million | -73.38 Million | 158.54 Million | 150.3 Million | -319.37 Million |
Debt repayment | -174.04 Million | -20.85 Million | -13 Million | -13.1 Million | -4.62 Million | -177.56 Million |
Dividends payments | -46.66 Million | -46.66 Million | -58.33 Million | -70 Million | -70 Million | -140 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 308.25 Million | -21.53 Million | -2.04 Million | 241.65 Million | 252.87 Million | -319.37 Million |
Accounts receivables | -6.44 Million | -29.26 Million | -8.67 Million | -1.85 Million | -17.76 Million | -30.72 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 16.51 Million | -16.82 Million | 25.93 Million | 6.1 Million | 2.91 Million | 9.27 Million |
Cash at beginning of period | 139.13 Million | 200.76 Million | 182.48 Million | 148.23 Million | 145.11 Million | 444.21 Million |
Cash at end of period | 176.94 Million | 139.13 Million | 200.76 Million | 182.48 Million | 148.23 Million | 145.11 Million |
Capital Expenditure | -2.26 Million | -487.34 Thousand | -293.13 Thousand | -743.63 Thousand | -624.1 Thousand | -689.85 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 37.8 Million | -61.62 Million | 18.27 Million | 34.24 Million | 3.12 Million | -299.1 Million |
Free Cash Flow | 151.1 Million | 113.65 Million | 181.29 Million | 98.38 Million | 113.83 Million | 99.99 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -8.52 Million | 4.71 Million | 36.41 Million | 3.32 Million | 13.61 Million | 16.11 Million |
Depreciation & Amortization | 9.43 Million | 9.42 Million | 34.17 Million | 9.59 Million | 8.61 Million | 7.7 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 22.52 Million | -12.3 Million | 10.06 Million | 10.1 Million | -1.31 Million | 10.64 Million |
Other non-cash items | 15.03 Million | 62.35 Million | 72.7 Million | 30.43 Million | 10.58 Million | 3.05 Million |
Investing Cash Flow | -60.88 Million | -56.8 Million | -203.1 Million | -25.06 Million | -179.78 Million | 69.42 Million |
Investments in PPE | -977.51 Thousand | -1.53 Million | -2.26 Million | -1.5 Million | -630.42 Thousand | - |
Acquisitions | - | - | -13 Million | -6.58 Million | - | - |
Investment purchases | -51.09 Million | -55.27 Million | -285.69 Million | -32.93 Million | 19 Million | 31 Million |
Sales/Maturities of investments | - | - | 84.85 Million | 2.96 Million | 31.27 Million | 50.61 Million |
Other Investing Activities | -58.37 Million | -55.27 Million | 13 Million | 12.99 Million | -229.43 Million | -12.18 Million |
Financing Cash Flow | -15.66 Million | -30 Million | 87.53 Million | -9.74 Million | 99.48 Million | 38.21 Million |
Debt repayment | -12.32 Million | -7.67 Million | -174.04 Million | -275.5 Thousand | -10.36 Million | -16.7 Million |
Dividends payments | - | -23.33 Million | -46.66 Million | -23.64 Million | -23.33 Million | -12.89 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.63 Million | -10.74 Million | 308.25 Million | 14.18 Million | 143.92 Million | 54.92 Million |
Accounts receivables | 9.78 Million | -26.9 Million | -6.44 Million | 20.06 Million | -1.97 Million | -19.92 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 4.98 Million | 14.6 Million | 16.51 Million | -9.96 Million | 652.16 Thousand | 30.57 Million |
Cash at beginning of period | 108.57 Million | 176.94 Million | 139.13 Million | 158.29 Million | 207.1 Million | 61.93 Million |
Cash at end of period | 95 Million | 108.57 Million | 176.94 Million | 176.94 Million | 158.29 Million | 207.1 Million |
Capital Expenditure | -977.51 Thousand | -1.53 Million | -2.26 Million | -1.5 Million | -630.42 Thousand | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -13.56 Million | -68.36 Million | 37.8 Million | 18.64 Million | -48.81 Million | 145.17 Million |
Free Cash Flow | 62 Million | 16.9 Million | 151.1 Million | 51.94 Million | 30.86 Million | 37.52 Million |
605055
025530
9698
GJNSF
AXFOS
CHEMCON